The Role of Hydrocortisone for Hypotension in Extremely Low Birth Weight Infants

---

ONLINECMECNENEO Grand Rounds

Instructions

Friday, August 6, 2021, 8:00 AM - Monday, August 5, 2024, 11:59 PM, Online


AMA PRA Category 1 Credits™ (1.00 hours), ANCC Nursing Contact Hour(s) (1.00 hours), Non-Physician (Attendance) (1.00 hours)

Extremely low birth weight (ELBW) infants are at risk for hypotension. The administration of hydrocortisone (HC) may be an effective treatment for hypotension in some infants. This presentation will address the trends in use of HC, dosing ranges and the associated risks.

1. Discuss the rationale for using hydrocortisone for hypotension.
2. Summarize the risks associated with the use of high dosage hydrocortisone.

1. Discuss the rationale for using hydrocortisone for hypotension.
2. Summarize the risks associated with the use of high dosage hydrocortisone.

The Mednax Center for Research, Education, Quality and Safety is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Mednax Center for Research, Education, Quality and Safety designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

---

The Mednax Center for Research, Education, Quality and Safety is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. 

The Mednax Center for Research, Education, Quality and Safety designates this Enduring Material for a maximum of 1.00 nursing contact hour(s). Participants should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation of Relevant Financial Relationships

The Mednax Center for Research, Education, Quality and Safety adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests) within the 24 months prior to their involvement with the CE activity. All relevant conflicts of interest have been mitigated prior to the commencement of the activity. 

There is no commercial support for this educational activity.